Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
A frequent form of acrocephalosyndactyly, a group of inherited congenital malformation disorders, characterized by craniosynostosis, midface hypoplasia, and finger and toe anomalies and/or syndactyly.
Metformin activates AMPK which phosphorylates ULK1, initiating autophagy. Enhanced autophagy degrades aggregated mutant FGFR2 proteins, reducing pathological signaling. AMPK also inhibits mTORC1, further reducing osteoblast hyperproliferation.
Small molecules that stabilize BMP7-BMPR1A interactions enhance SMAD1/5/8 phosphorylation, promoting osteoblast differentiation over proliferation. This counterbalances FGFR2-driven proliferative signals in cranial sutures.
Curcumin inhibits NF-κB and AP-1 transcription factors downstream of mutant FGFR2, while MEK inhibition blocks ERK1/2-mediated osteoblast proliferation. Combined approach targets both inflammatory and proliferative pathways driving premature suture fusion.
Withanoside IV and withaferin A bind to allosteric sites on FGFR2 kinase domain, reducing kinase activity without complete inhibition. This restores normal FGF signaling balance while preserving essential developmental functions.
Berberine directly binds PI3Kα catalytic domain, blocking downstream AKT phosphorylation. This interrupts mutant FGFR2-mediated survival signals in rapidly dividing cranial suture cells, allowing normal apoptosis and preventing premature fusion.
Gomisin N selectively binds FGFR2 ATP-binding pocket due to unique hydrogen bonding pattern, inhibiting kinase activity. Additional neuroprotective effects through Nrf2 activation may address cognitive symptoms in Apert syndrome.